Indrayani Biotech Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 525226,
    "name": "Indrayani Biotec",
    "stock_name": "Indrayani Biotec",
    "full_name": "Indrayani Biotech Ltd",
    "name_url": "stocks-analysis/indrayani-biotec",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "9.15",
    "chg": 0.01,
    "chgp": "0.11%",
    "dir": 1,
    "prev_price": "9.14",
    "mcapval": "43.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 526445,
    "symbol": "",
    "ind_name": "Other Agricultural Products",
    "ind_code": 101,
    "indexname": "",
    "isin": "INE007C01021",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "10.21 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/indrayani-biotec-525226-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "How has been the historical performance of Indrayani Biotec?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-indrayani-biotec-3702841",
        "imagepath": "",
        "date": "2025-11-14 23:35:17",
        "description": "Answer:\nThe historical performance of Indrayani Biotec has shown significant fluctuations over the years, particularly in net sales and profitability.\n\nBreakdown:\nIndrayani Biotec's net sales peaked at 166.23 Cr in March 2024 but fell to 130.23 Cr by March 2025. The total operating income followed a similar trend, decreasing from 166.23 Cr in March 2024 to 130.23 Cr in March 2025. The company experienced a notable increase in raw material costs, which reached 82.77 Cr in March 2025, down from 97.13 Cr in March 2024. Operating profit (PBDIT) also declined from 24.66 Cr in March 2024 to 18.36 Cr in March 2025, while profit before tax turned negative at -5.74 Cr in March 2025 after being positive at 10.97 Cr in March 2024. Consequently, the profit after tax also fell to -6.11 Cr in March 2025 from 10.42 Cr in March 2024. The earnings per share (EPS) reflected this downturn, dropping to -1.34 in March 2025 from..."
      },
      {
        "title": "Are Indrayani Biotec latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-indrayani-biotec-latest-results-good-or-bad-3702163",
        "imagepath": "",
        "date": "2025-11-14 19:27:00",
        "description": "Indrayani Biotech has reported its financial results for the quarter ending June 2025, reflecting significant challenges in its operational performance. The company's net sales amounted to Rs 29.10 crore, which represents a year-on-year decline of 7.71%. This decline in sales is notable, especially when compared to the previous year's performance.\n\nThe Profit Before Tax (PBT) has fallen to Rs -0.85 crore, indicating a substantial decline year-on-year. Similarly, the Profit After Tax (PAT) has decreased to Rs 0.16 crore, showing an 81.18% reduction compared to the same quarter last year. These figures suggest that the company is facing considerable pressure on its profitability.\n\nAdditionally, the inventory turnover ratio has reached a low of 3.15 times, which may signal a slowdown in inventory movement and could raise concerns about operational efficiency. The non-operating income has increased significantl..."
      },
      {
        "title": "Why is Indrayani Biotec falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-indrayani-biotec-fallingrising-3698481",
        "imagepath": "",
        "date": "2025-11-13 21:38:23",
        "description": "As of 13-Nov, Indrayani Biotech Ltd's stock price is currently at 14.78, reflecting a decrease of 0.29, or 1.92%. The stock has been experiencing a downward trend, having lost 3.46% over the last two days, and it has underperformed significantly over the past year with a decline of 65.14%. The stock's performance today is in line with the sector, which has also seen a decline of 2.04%. Additionally, there has been a notable drop in investor participation, with delivery volume falling by 90.13% compared to the 5-day average, indicating reduced interest in trading the stock. The stock is currently trading above its 20-day, 50-day, and 100-day moving averages but below its 5-day and 200-day moving averages, suggesting mixed signals regarding its short-term momentum.\n\nBroader Market Context: In the context of the broader market, the Sensex has gained 1.40% over the past week, contrasting sharply with Indrayani ..."
      },
      {
        "title": "Why is Indrayani Biotec falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-indrayani-biotec-fallingrising-3676567",
        "imagepath": "",
        "date": "2025-11-06 21:24:43",
        "description": "As of 06-Nov, Indrayani Biotech Ltd's stock price is currently at 15.60, reflecting an increase of 1.34, or 9.4%. The stock has been gaining momentum, having risen for the last two days with a total return of 11.67% during this period. It opened with a gain of 4.77% today and reached an intraday high of Rs 16.47, although it also experienced a low of Rs 13.72. The stock has shown high volatility today, with an intraday volatility of 9.07%. Additionally, the stock's performance over the past week has been strong, with a return of 11.43%, contrasting sharply with the Sensex, which declined by 1.30%. However, the stock is still down significantly year-to-date by 57.12% and has a longer-term decline of 66.73% over the past year.\n\nIn the broader market context, while Indrayani Biotech's short-term performance has outpaced the benchmark Sensex, which gained only 1.86% over the past month, the stock's year-to-date..."
      }
    ],
    "total": 684,
    "sid": "525226",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/indrayani-biotech-525226"
  },
  "announcements": [
    {
      "caption": "Defaults under Para A sub-paragraph 6 of Schedule III-Initial Disclosure",
      "datetime": "31-Jan-2026",
      "details": "A Demand Notice paper publication has been issued to the Company by Hinduja Leyland Finance Limited for the default in outstanding term loan provided by them",
      "source": "BSE"
    },
    {
      "caption": "Defaults under Para A sub-paragraph 6 of Schedule III-Initial Disclosure",
      "datetime": "31-Jan-2026",
      "details": "A Demand Notice paper publication has been issued to the Company by Hinduja Leyland Finance Limited for the default in outstanding term loan provided by them",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "05-Jan-2026",
      "details": "Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 31st December 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

How has been the historical performance of Indrayani Biotec?

2025-11-14 23:35:17

Answer: The historical performance of Indrayani Biotec has shown significant fluctuations over the years, particularly in net sales and profitability. Breakdown: Indrayani Biotec's net sales peaked at 166.23 Cr in March 2024 but fell to 130.23 Cr by March 2025. The total operating income followed a similar trend, decreasing from 166.23 Cr in March 2024 to 130.23 Cr in March 2025. The company experienced a notable increase in raw material costs, which reached 82.77 Cr in March 2025, down from 97.13 Cr in March 2024. Operating profit (PBDIT) also declined from 24.66 Cr in March 2024 to 18.36 Cr in March 2025, while profit before tax turned negative at -5.74 Cr in March 2025 after being positive at 10.97 Cr in March 2024. Consequently, the profit after tax also fell to -6.11 Cr in March 2025 from 10.42 Cr in March 2024. The earnings per share (EPS) reflected this downturn, dropping to -1.34 in March 2025 from...

Are Indrayani Biotec latest results good or bad?

2025-11-14 19:27:00

Indrayani Biotech has reported its financial results for the quarter ending June 2025, reflecting significant challenges in its operational performance. The company's net sales amounted to Rs 29.10 crore, which represents a year-on-year decline of 7.71%. This decline in sales is notable, especially when compared to the previous year's performance. The Profit Before Tax (PBT) has fallen to Rs -0.85 crore, indicating a substantial decline year-on-year. Similarly, the Profit After Tax (PAT) has decreased to Rs 0.16 crore, showing an 81.18% reduction compared to the same quarter last year. These figures suggest that the company is facing considerable pressure on its profitability. Additionally, the inventory turnover ratio has reached a low of 3.15 times, which may signal a slowdown in inventory movement and could raise concerns about operational efficiency. The non-operating income has increased significantl...

Why is Indrayani Biotec falling/rising?

2025-11-13 21:38:23

As of 13-Nov, Indrayani Biotech Ltd's stock price is currently at 14.78, reflecting a decrease of 0.29, or 1.92%. The stock has been experiencing a downward trend, having lost 3.46% over the last two days, and it has underperformed significantly over the past year with a decline of 65.14%. The stock's performance today is in line with the sector, which has also seen a decline of 2.04%. Additionally, there has been a notable drop in investor participation, with delivery volume falling by 90.13% compared to the 5-day average, indicating reduced interest in trading the stock. The stock is currently trading above its 20-day, 50-day, and 100-day moving averages but below its 5-day and 200-day moving averages, suggesting mixed signals regarding its short-term momentum. Broader Market Context: In the context of the broader market, the Sensex has gained 1.40% over the past week, contrasting sharply with Indrayani ...

Why is Indrayani Biotec falling/rising?

2025-11-06 21:24:43

As of 06-Nov, Indrayani Biotech Ltd's stock price is currently at 15.60, reflecting an increase of 1.34, or 9.4%. The stock has been gaining momentum, having risen for the last two days with a total return of 11.67% during this period. It opened with a gain of 4.77% today and reached an intraday high of Rs 16.47, although it also experienced a low of Rs 13.72. The stock has shown high volatility today, with an intraday volatility of 9.07%. Additionally, the stock's performance over the past week has been strong, with a return of 11.43%, contrasting sharply with the Sensex, which declined by 1.30%. However, the stock is still down significantly year-to-date by 57.12% and has a longer-term decline of 66.73% over the past year. In the broader market context, while Indrayani Biotech's short-term performance has outpaced the benchmark Sensex, which gained only 1.86% over the past month, the stock's year-to-date...

View All News